Skip to main content
icon for Proposta di legame per la ricerca immunologica in California

Proposta di legame per la ricerca immunologica in California

icon for Proposta di legame per la ricerca immunologica in California

Proposta di legame per la ricerca immunologica in California

54% probabilità
Polymarket
NUOVO

54% probabilità
Polymarket
NUOVO
Proposition 38 is a California ballot measure currently scheduled for voting on November 3, 2026. It would allow the state to borrow $8.4 billion in debt to research immune system-based technologies for treating conditions including cancer, heart disease and Alzheimer’s. This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.” If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”. This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).California Proposition 38, set for the November 2026 ballot, would authorize $8.4 billion in general obligation bonds for immunology and immunotherapy research, with half directed to a designated University of California-affiliated institute and the balance awarded via competitive grants, at least $4.2 billion of which must target cancer, heart disease, and Alzheimer’s. Trader sentiment favoring rejection at 55% reflects concerns over the measure’s eligibility criteria, which critics note appear structured to channel substantial funds to one specific nonprofit backed by its billionaire co-founder, alongside broader worries about long-term General Fund repayment obligations and fragmented state research priorities. Recent analyses from the Legislative Analyst’s Office and opinion pieces have highlighted these design elements and debt implications, contributing to the current market positioning ahead of the vote.

Proposition 38 is a California ballot measure currently scheduled for voting on November 3, 2026. It would allow the state to borrow $8.4 billion in debt to research immune system-based technologies for treating conditions including cancer, heart disease and Alzheimer’s.

This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.”

If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”.

This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).
Volume
$2,851
Data di fine
3 nov 2026
Mercato aperto
Jul 1, 2026, 6:33 PM ET
Proposition 38 is a California ballot measure currently scheduled for voting on November 3, 2026. It would allow the state to borrow $8.4 billion in debt to research immune system-based technologies for treating conditions including cancer, heart disease and Alzheimer’s. This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.” If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”. This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).
Proposition 38 is a California ballot measure currently scheduled for voting on November 3, 2026. It would allow the state to borrow $8.4 billion in debt to research immune system-based technologies for treating conditions including cancer, heart disease and Alzheimer’s. This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.” If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”. This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).California Proposition 38, set for the November 2026 ballot, would authorize $8.4 billion in general obligation bonds for immunology and immunotherapy research, with half directed to a designated University of California-affiliated institute and the balance awarded via competitive grants, at least $4.2 billion of which must target cancer, heart disease, and Alzheimer’s. Trader sentiment favoring rejection at 55% reflects concerns over the measure’s eligibility criteria, which critics note appear structured to channel substantial funds to one specific nonprofit backed by its billionaire co-founder, alongside broader worries about long-term General Fund repayment obligations and fragmented state research priorities. Recent analyses from the Legislative Analyst’s Office and opinion pieces have highlighted these design elements and debt implications, contributing to the current market positioning ahead of the vote.

Proposition 38 is a California ballot measure currently scheduled for voting on November 3, 2026. It would allow the state to borrow $8.4 billion in debt to research immune system-based technologies for treating conditions including cancer, heart disease and Alzheimer’s.

This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.”

If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”.

This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).
Volume
$2,851
Data di fine
3 nov 2026
Mercato aperto
Jul 1, 2026, 6:33 PM ET
Proposition 38 is a California ballot measure currently scheduled for voting on November 3, 2026. It would allow the state to borrow $8.4 billion in debt to research immune system-based technologies for treating conditions including cancer, heart disease and Alzheimer’s. This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.” If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”. This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).

Fai attenzione ai link esterni.

Domande frequenti

"Proposta di legame per la ricerca immunologica in California" è un mercato predittivo su Polymarket con 2 possibili esiti dove i trader comprano e vendono azioni in base a ciò che credono accadrà. L'esito attualmente in testa è "Proposta di Obbligazioni per la Ricerca in Immunologia della California" a 45%. I prezzi riflettono probabilità aggregate in tempo reale. Ad esempio, un'azione quotata a 45¢ implica che il mercato assegna collettivamente una probabilità di 45% a quell'esito. Queste quote cambiano continuamente man mano che i trader reagiscono a nuovi sviluppi e informazioni. Le azioni nell'esito corretto possono essere riscattate per $1 ciascuna alla risoluzione del mercato.

"Proposta di legame per la ricerca immunologica in California" è un mercato appena creato su Polymarket, lanciato il Jul 1, 2026. Come mercato nuovo, questa è la tua opportunità di essere tra i primi trader a stabilire le quote e i segnali di prezzo iniziali del mercato. Puoi anche aggiungere questa pagina ai preferiti per monitorare il volume e l'attività di trading man mano che il mercato guadagna visibilità.

Per fare trading su "Proposta di legame per la ricerca immunologica in California", esplora i 2 esiti disponibili elencati in questa pagina. Ogni esito mostra un prezzo corrente che rappresenta la probabilità implicita del mercato. Per prendere una posizione, seleziona l'esito che ritieni più probabile, scegli "Sì" per fare trading a suo favore o "No" per fare trading contro di esso, inserisci il tuo importo e clicca "Trading". Se il tuo esito scelto è corretto alla risoluzione del mercato, le tue azioni "Sì" pagano $1 ciascuna. Se è errato, pagano $0. Puoi anche vendere le tue azioni in qualsiasi momento prima della risoluzione se vuoi consolidare un profitto o limitare una perdita.

L'attuale favorito per "Proposta di legame per la ricerca immunologica in California" è "Proposta di Obbligazioni per la Ricerca in Immunologia della California" a 45%, il che significa che il mercato assegna una probabilità di 45% a quell'esito. Queste quote si aggiornano in tempo reale man mano che i trader comprano e vendono azioni, quindi riflettono l'ultima visione collettiva di ciò che è più probabile che accada. Controlla frequentemente o aggiungi questa pagina ai preferiti per seguire come cambiano le quote man mano che emergono nuove informazioni.

Le regole di risoluzione per "Proposta di legame per la ricerca immunologica in California" definiscono esattamente cosa deve accadere affinché ogni esito venga dichiarato vincitore — comprese le fonti di dati ufficiali utilizzate per determinare il risultato. Puoi consultare i criteri completi di risoluzione nella sezione "Regole" di questa pagina sopra i commenti. Ti consigliamo di leggere attentamente le regole prima di fare trading, poiché specificano le condizioni precise, i casi limite e le fonti che regolano come viene risolto questo mercato.